Andere talen Royalty Pharma plc

Aandelen

RPRX

GB00BMVP7Y09

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
28 ^USD	-0,39%		-0,57%	-0,32%

17/04	Royalty Pharma plc kondigt dividend aan voor het tweede kwartaal van 2024, betaalbaar op 14 juni 2024	CI
09/04	ROYALTY PHARMA PLC : Morgan Stanley herhaalt koopadvies	ZM

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Fitch Affirms Royalty Pharma plc at 'BBB-'; Outlook Stable	22/04
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024	19/04
Royalty Pharma Maintains Quarterly Dividend at $0.21 per Share, Payable June 14 to Shareholders of Record May 17	17/04
Royalty Pharma Declares Second Quarter 2024 Dividend	17/04
Royalty Pharma plc Declares Dividend for the Second Quarter of 2024, Payable on June 14, 2024	17/04
Royalty Pharma : EEO-1 2023 Consolidated Report	03/04
Royalty Pharma : TD Cowen Health Care Conference Transcript	07/03
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference	28/02
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference	28/02
Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023.	15/02
Royalty Pharma plc Reports Earnings Results for the Full Year Ended December 31, 2023	15/02
Royalty Pharma Swings to Q4 Net Income, Revenue Increases	15/02
Royalty Pharma: Q4 Earnings Snapshot	15/02
Royalty Pharma plc Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	15/02
Earnings Flash (RPRX) ROYALTY PHARMA Reports Q4 Revenue $596M, vs. Street Est of $674.5M	15/02
Royalty Pharma Reports Q4 and Full Year 2023 Results	15/02
Royalty Pharma Reports Q4 and Full Year 2023 Results	15/02
Novartis will Morphosys schlucken - Zugriff auf Hoffnungsträger	06/02
Novartis data42 AG entered into an agreement to make a voluntary public takeover offer to acquire MorphoSys AG for ?2.7 billion.	05/02
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024	30/01

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Royalty Pharma plc

Aandelen

RPRX

GB00BMVP7Y09

Andere talen

Filters